Description
Vulnerability in the Oracle Production Scheduling product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Difficult to exploit vulnerability allows high privileged attacker with logon to the infrastructure where Oracle Production Scheduling executes to compromise Oracle Production Scheduling. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Production Scheduling accessible data. CVSS 3.1 Base Score 1.9 (Integrity impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:H/PR:H/UI:N/S:U/C:N/I:L/A:N).
No analysis available yet.
Remediation
No remediation available yet.
Tracking
Sign in to view the affected projects.
Advisories
No advisories yet.
References
| Link | Providers |
|---|---|
| https://www.oracle.com/security-alerts/cpujul2026.html |
|
History
Tue, 21 Jul 2026 22:00:00 +0000
| Type | Values Removed | Values Added |
|---|---|---|
| Description | Vulnerability in the Oracle Production Scheduling product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Difficult to exploit vulnerability allows high privileged attacker with logon to the infrastructure where Oracle Production Scheduling executes to compromise Oracle Production Scheduling. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Production Scheduling accessible data. CVSS 3.1 Base Score 1.9 (Integrity impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:H/PR:H/UI:N/S:U/C:N/I:L/A:N). | |
| First Time appeared |
Oracle
Oracle production Scheduling |
|
| CPEs | cpe:2.3:a:oracle:production_scheduling:*:*:*:*:*:*:*:* | |
| Vendors & Products |
Oracle
Oracle production Scheduling |
|
| References |
| |
| Metrics |
cvssV3_1
|
Status: PUBLISHED
Assigner: oracle
Published:
Updated: 2026-07-21T21:37:51.480Z
Reserved: 2026-07-08T15:51:55.610Z
Link: CVE-2026-61047
No data.
No data.
No data.
OpenCVE Enrichment
No data.
Weaknesses
No weakness.